|
Status |
Public on Jan 31, 2008 |
Title |
045_07_02 |
Sample type |
RNA |
|
|
Source name |
Pre-treatment metastatic biopsy of CRC
|
Organism |
Homo sapiens |
Characteristics |
Tissue: Abdomen (soft tissue mass)
|
Extracted molecule |
total RNA |
Extraction protocol |
RNA isolated from core-needle biopsy stored in RNAlater at RT using RNeasy Mini Kit (Qiagen)according to the manufacturer's instructions.
|
Label |
biotin
|
Label protocol |
Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 1 microg total RNA RNA!Sample_hyb_protocol = Standard Affymetrix procedures
|
|
|
Scan protocol |
GeneChips were scanned using the Affymetrix GeneChip Scanner 3000
|
Description |
Gene expression data from pre-cetuximab monotherapy treatment biopsies of advanced metastatic colorectal cancer patients
|
Data processing |
Data scaled to 1500 mean signal intensity value using GCOS 1.1.1.052
|
|
|
Submission date |
Sep 15, 2006 |
Last update date |
Aug 28, 2007 |
Contact name |
Shirin Khambata Ford |
E-mail(s) |
shirin.ford@bms.com
|
Organization name |
Bristol-Myers Squibb Pharmaceutical Research Institute
|
Street address |
311 Pennington-Rocky Hill Road, 3B-2.06
|
City |
Pennington |
State/province |
NJ |
ZIP/Postal code |
08534 |
Country |
USA |
|
|
Platform ID |
GPL571 |
Series (1) |
GSE5851 |
Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
|